Arrowstreet Capital
GRDN

Arrowstreet Capital’s Guardian Pharmacy Services GRDN Stock Holding History

Arrowstreet Capital’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.44M Buy
38,185
+16,866
+79% +$551K ﹤0.01% 1473
2025
Q4 		$641K Buy
+21,319
New +$603K ﹤0.01% 1647

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Arrowstreet Capital's GRDN Position: Q1 2026 in Review

Arrowstreet Capital increased its Guardian Pharmacy Services (GRDN) stake by 79% in Q1 2026, buying an estimated $551K and bringing the position to 38,185 shares worth $1.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1473.

Arrowstreet Capital first reported a position in GRDN in Q4 2025 and has held it in 2 quarters since. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • Arrowstreet Capital held 38,185 shares of Guardian Pharmacy Services worth $1.44M as of Q1 2026.
  • Arrowstreet Capital bought 16,866 Guardian Pharmacy Services shares in Q1 2026, an estimated $551K.
  • Guardian Pharmacy Services made up ﹤0.01% of Arrowstreet Capital's portfolio in Q1 2026, its #1473 holding.
  • Arrowstreet Capital first reported a position in Guardian Pharmacy Services in Q4 2025 and has held it in 2 quarters since.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.